Treatment of paediatric trigger finger: a systematic review and treatment algorithm

M E Womack1, J C Ryan1, V Shillingford-Cole1

  • 1Department of Orthopaedic Surgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.

Insights

Paediatric trigger finger (PTF) management lacks consensus. A literature review suggests a step-wise approach combining non-operative and surgical treatments for children with trigger finger offers high resolution rates.

Area of Science:

  • Paediatric Orthopaedics
  • Hand Surgery
  • Systematic Review

Background:

  • Paediatric trigger finger (PTF) is a rare condition with limited published research.
  • Current treatment strategies for PTF lack established consensus.
  • This rarity necessitates a review to guide clinical decision-making.

Purpose of the Study:

  • To systematically review existing literature on paediatric trigger finger treatment options.
  • To develop a proposed step-wise treatment algorithm for paediatric trigger finger.
  • To inform clinical practice for managing this condition in children.

Main Methods:

  • A systematic literature review was performed using PubMed.
  • English language studies reporting on PTF treatment interventions were included.
  • Data on patient numbers, finger involvement, interventions, and outcomes were collected, adhering to PRISMA guidelines.

Main Results:

  • Seven articles comprising 118 trigger fingers were analyzed.
  • Non-surgical treatment resolved 57.8% of cases; initial surgical treatment resolved 87%.
  • Overall symptom resolution after all interventions reached 92.4%.

Conclusions:

  • The rarity of PTF contributes to small sample sizes and limited prospective studies.
  • A structured, step-wise treatment approach incorporating both non-operative and surgical methods is recommended for PTF management.
  • This systematic review supports a guided algorithm for effective PTF treatment.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K